SUPPRESSION OF IN-VITRO TYPE-17 RESPONSES IN SPA PATIENTS USING SMALL MOLECULE ROR-gamma T INHIBITORS
Príomhchruthaitheoirí: | De Wit, J, Al-Mossawi, M, Huhn, M, Arancibia, C, Powrie, F, Bowness, P |
---|---|
Formáid: | Journal article |
Foilsithe / Cruthaithe: |
2014
|
Míreanna comhchosúla
Míreanna comhchosúla
-
RORγt inhibitors suppress TH17 responses in inflammatory arthritis and inflammatory bowel disease.
de réir: de Wit, J, et al.
Foilsithe / Cruthaithe: (2015) -
Small molecule inhibitors of RORγt for Th17 regulation in inflammatory and autoimmune diseases
de réir: Jiuping Zeng, et al.
Foilsithe / Cruthaithe: (2023-06-01) -
BROMODOMAIN INHIBITORS REDUCE TH17-TYPE RESPONSES IN SPONDYLOARTHRITIS IN VITRO
de réir: Hammitzsch, A, et al.
Foilsithe / Cruthaithe: (2014) -
Small molecule allosteric inhibitors of RORγt block Th17-dependent inflammation and associated gene expression in vivo.
de réir: Steven A Saenz, et al.
Foilsithe / Cruthaithe: (2021-01-01) -
Small molecule allosteric inhibitors of RORγt block Th17-dependent inflammation and associated gene expression in vivo
de réir: Steven A. Saenz, et al.
Foilsithe / Cruthaithe: (2021-01-01)